Nontuberculous Mycobacteria in Primary Ciliary Dyskinesia: A National Multicenter Cohort Study
Respiration · 28.05.2026 · 1-10
DOI: 10.1159/000552722 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Respiration, online erschienen am 28.05.2026. Verfasst von Ophir Bar-On und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonology Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel, ophirbaron@tauex.tau.ac.il. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
The prevalence and clinical significance of nontuberculous mycobacteria (NTM) in individuals with primary ciliary dyskinesia (PCD) remain unclear, with most data extrapolated from cystic fibrosis. This first national multicenter cohort study evaluating NTM in PCD patients aimed to determine the prevalence, species distribution, and clinical impact of NTM isolation.
Methods
A retrospective, longitudinal study was conducted across four tertiary centers in Israel (2010–2024). Patients with confirmed PCD were evaluated for demographic, clinical, microbiological, and longitudinal lung function data. NTM species were classified by growth rate and pathogenicity. Each NTM-positive PCD patient was matched 1:1 to an NTM-negative PCD patient.
Results
Of 231 patients with PCD, 24 (10.4%) had ≥1 positive NTM culture. Most isolates were slow-growing species, predominantly Mycobacterium simiae. Rapid-growing species, mainly Mycobacterium abscessus, were identified in patients with significantly lower forced expiratory volume in 1 s (FEV1) at the time of NTM isolation when compared with those harboring slow-growing species (43.5% vs. 82.3%, p = 0.03). Chronic isolation occurred in 25% of NTM-positive individuals. Longitudinal analysis showed no significant association between NTM status and FEV1 decline. Intravenous antibiotic use was not higher in NTM-positive patients and did not increase following NTM isolation. Only one patient fulfilled the criteria for NTM pulmonary disease.
Conclusion
NTM isolation is not uncommon in PCD patients and is often intermittent, mostly by slow-growing species. NTM status was not associated with accelerated FEV1 decline, although rapid growers occurred predominantly in patients with poorer baseline lung function. Routine annual NTM surveillance appears reasonable to better determine prevalence and monitor outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pulmonology Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel, ophirbaron@tauex.tau.ac.il.
- School of Medicine, Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel, ophirbaron@tauex.tau.ac.il.
- Pulmonology Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
- School of Medicine, Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.
- Department of Clinical Microbiology, Rabin Medical Center, Petah Tikva, Israel.
- Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Zitieren
APA
Bar-On, O., Less Elazari, S., Ben Zvi, H., Yaacoby-Bianu, K., Raz, I., Bar-Yoseph, R., Gur, M., Golan Tripto, I., Gatt, D., Mussaffi, H., Heching, M., Prais, D., & Dotan, M. (2026). Nontuberculous Mycobacteria in Primary Ciliary Dyskinesia: A National Multicenter Cohort Study. Respiration, 1-10. https://doi.org/10.1159/000552722
Vancouver
Bar-On O, Less Elazari S, Ben Zvi H, Yaacoby-Bianu K, Raz I, Bar-Yoseph R, et al. Nontuberculous Mycobacteria in Primary Ciliary Dyskinesia: A National Multicenter Cohort Study. Respiration. 2026:1-10. doi:10.1159/000552722
BibTeX
@article{BarOn2026,
author = {Bar-On, Ophir and Less Elazari, Saharon and Ben Zvi, Haim and Yaacoby-Bianu, Karin and Raz, Idit and Bar-Yoseph, Ronen and Gur, Michal and Golan Tripto, Inbal and Gatt, Dvir and Mussaffi, Huda and Heching, Moshe and Prais, Dario and Dotan, Miri},
title = {Nontuberculous Mycobacteria in Primary Ciliary Dyskinesia: A National Multicenter Cohort Study},
journal = {Respiration},
year = {2026},
pages = {1--10},
doi = {10.1159/000552722}
}
EUVIMED